Radiosurgery Alters the Endothelial Surface Proteome: Externalized Intracellular Molecules as Potential Vascular

Lucinda S McRobb1, Vivienne S Lee1, Margaret Simonian1,2

  • 1a   Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia.

Radiation Research
|January 6, 2017
PubMed

Insights

Stereotactic radiosurgery (SRS) primes brain arteriovenous malformations (AVMs) by altering endothelial proteins. This study identifies novel surface proteins after SRS, offering potential targets for rapid AVM closure.

Area of Science:

  • Vascular Biology
  • Radiosurgery
  • Proteomics

Background:

  • Stereotactic radiosurgery (SRS) treats brain arteriovenous malformations (AVMs) but has limitations.
  • Current SRS treatment for AVMs has a 2-3 year delay for vessel closure and a size restriction.

Purpose of the Study:

  • To investigate novel protein expression on AVM endothelium after SRS.
  • To identify potential targets for rapid thrombosis and vessel closure in AVMs.

Main Methods:

  • Used SRS as a priming tool in an animal AVM model.
  • Employed in vivo biotin labeling and comparative proteomics (LC-MS/MS) to analyze surface proteins.
  • Validated protein changes using immunostaining and in vitro cell studies.

Main Results:

  • Identified 280 proteins in biotin-enriched fractions, with 56 showing increased abundance post-irradiation.
  • Cardiac troponin I (TNNI3), manganese superoxide dismutase (SOD2), and pyruvate dehydrogenase complex E2 subunit (PDCE2) were validated.
  • Radiation primarily affected subcellular distribution of these proteins, not total levels, with PDCE2 showing increased abundance in the vessel wall.

Conclusions:

  • Novel surface-exposed proteins identified post-SRS in AVMs.
  • These proteins may play a role in radiation-induced inflammation and autoimmunity.
  • Identified proteins are potential candidates for targeted vascular therapy in AVMs and other vascular conditions.